webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Maleimide-PEG2-hydrazide TFA

  CAS No.:   Cat No.: BADC-01270   Purity: ≥95% 4.5  

Maleimide-PEG2-hydrazide TFA is a cleavable ADC linker with maleimide for thiol conjugation and hydrazide for hydrazone chemistry. Ideal for antibody-drug conjugates with controlled payload release and enhanced stability.

Maleimide-PEG2-hydrazide TFA

Structure of

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C16H23F3N4O8
Molecular Weight
456.37
Shipping
Room temperature
Shipping
Store at -20 °C, keep in dry and avoid sunlight.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
IUPAC Name
Solubility
10 mm in DMSO
Shelf Life
-20°C 3 years powder; -80°C 2 years in solvent
Shipping
Room temperature
Storage
Store at -20 °C, keep in dry and avoid sunlight.

Maleimide-PEG2-hydrazide TFA is a versatile compound commonly used in bioconjugation and targeted drug delivery systems. The maleimide group is highly reactive with thiol groups on proteins, peptides, or antibodies, enabling the formation of stable covalent bonds. The PEG2 spacer, a short polyethylene glycol chain, provides enhanced solubility, reduces immunogenicity, and improves the pharmacokinetics of the conjugate. The hydrazide functional group is useful for further conjugation reactions, such as linking the compound to aldehydes or ketones on biomolecules. The trifluoroacetic acid (TFA) salt form ensures stability and ease of handling during synthesis and storage. This structure makes Maleimide-PEG2-hydrazide TFA ideal for creating highly specific and stable conjugates for therapeutic, diagnostic, and research applications.

One key application of Maleimide-PEG2-hydrazide TFA is in the development of targeted antibody-drug conjugates (ADCs) for cancer therapy. By conjugating cytotoxic drugs to antibodies through the maleimide linkage, the compound allows for the selective delivery of drugs directly to tumor cells. The PEG2 spacer enhances the solubility and stability of the conjugate, which is crucial for maintaining its effectiveness during circulation. The hydrazide group can further be used to attach the cytotoxic agent or imaging probe to the antibody, enhancing targeting specificity and reducing off-target toxicity. This method is particularly useful for therapies where traditional chemotherapy fails to target specific cancer cells.

Maleimide-PEG2-hydrazide TFA is also widely employed in the synthesis of diagnostic probes, particularly for cancer imaging. The hydrazide functionality allows for the efficient conjugation of imaging agents, such as fluorescent dyes or radiolabeled compounds, to antibodies or peptides that specifically bind to tumor antigens. The maleimide group facilitates selective conjugation to thiol groups on the targeting molecules, ensuring that the probe is directed precisely to the site of interest. This application is valuable for non-invasive imaging techniques like positron emission tomography (PET) or fluorescence imaging, which provide critical information for early detection, tumor localization, and treatment monitoring.

In addition to drug delivery and diagnostic applications, Maleimide-PEG2-hydrazide TFA is also utilized in the study of protein interactions and biomolecular engineering. The hydrazide group is a useful tool for labeling proteins, peptides, or nucleic acids with aldehyde- or ketone-functionalized molecules, enabling the tracking and analysis of biomolecular interactions. This can be particularly valuable in proteomics, where understanding protein-protein interactions or cellular localization is critical for studying disease mechanisms. The PEG2 spacer reduces steric hindrance and enhances the solubility of the conjugates, making it easier to study interactions in complex biological environments. This versatility makes Maleimide-PEG2-hydrazide TFA an important reagent in biomolecular research and diagnostics.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: N-[6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoyl]-L-valyl-L-alanine | MC-PEG2-NH2 | tert-Butyl 1-oxo-3,6,9,12-tetraoxapentadecan-15-oate
Send Inquiry
Verification code
Inquiry Basket